Skip to main content

Table 1 Summary of patient characteristics

From: Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis

Characteristic

Atomoxetine

Methylphenidate

Total

Age mean (SD)

   

Gender n(%)

   

Male

1030 (79.8)

973(75.4)

2003(77.6)

Female

260(20.2)

317(25.6)

577 (22.4)

Ethnic origin

   

Caucasian

871 (61.8)

946 (72.7)

1817(67.0)

Others

539 (38.2)

355 (27.3)

894(33.0)

ADHD subtype

   

Hyperactive/impulsive

19 (2.3)

11 (2.0)

30 (2.2)

Inattentive

191 (23.3)

152 (28.3)

343(25.3)

combined

609 (74.4)

374 (69.7)

983 (72.5)

Prior stimulant use- yes

544 (55.0)

528 (41.4)

1072 (47.4)

Comorbid oppositional defiant disorder

273 (39.0)

134 (31.1)

407(36.0)